Valuation: InterCure Ltd.

Market Cap 17Cr 0 15Cr 14Cr 13Cr 24Cr 1.64TCr 25Cr 164.28Cr 64Cr 818.59Cr 65Cr 63Cr 2.74TCr P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 31Cr 0 27Cr 25Cr 23Cr 43Cr 2.95TCr 44Cr 294.31Cr 115.51Cr 1.47TCr 115.89Cr 113.35Cr 4.92TCr EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+9.34%
1 week+7.11%
1 month-7.05%
3 months+18.33%
6 months+7.73%
Current year-2.66%
1 week 274
Extreme 274
315
1 month 274
Extreme 274
343.3
Current year 225.3
Extreme 225.3
359
1 year 225.3
Extreme 225.3
605
3 years 225.3
Extreme 225.3
1,346
5 years 225.3
Extreme 225.3
2,635
10 years 146.83
Extreme 146.8255
6,317.95
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/03/26 Other

Director

15,000 0.0274%
09/11/22 Option

Chief Financial Officer

2,30,000 0.5066%
09/11/22 Option 2,30,000 0.5066%
Change 5-day change 1-year change 3-year change Capi.($)
+9.34%+7.11%-38.28%-45.99% 5.62Cr
-3.52%-0.52%+24.68%+212.20% 22Cr
-3.68%-0.76%-29.19%-33.84% 13Cr
-1.06%-2.11%-1.06%+78.85% 13Cr
+1.23%+5.00%-29.98%-8.07% 8.39Cr
-3.70%-.--%-.--%-36.07% 7.92Cr
Average -0.23%+0.62%-12.31%+27.85% 11.69Cr
Weighted average by Cap. -1.51%-0.13%-4.58%+66.19%

Financials

2024 2025
Net sales 24Cr 0 21Cr 19Cr 18Cr 34Cr 2.28TCr 34Cr 227.8Cr 89Cr 1.14TCr 90Cr 88Cr 3.81TCr 27Cr 0 23Cr 22Cr 20Cr 38Cr 2.58TCr 38Cr 257.7Cr 101.14Cr 1.28TCr 101.48Cr 99Cr 4.31TCr
Net income -6.78Cr -0 -5.89Cr -5.49Cr -5.04Cr -9.51Cr -647.17Cr -9.66Cr -65Cr -25Cr -322.19Cr -25Cr -25Cr -1.08TCr -3.57Cr -0 -3.1Cr -2.89Cr -2.65Cr -5.01Cr -340.89Cr -5.09Cr -34Cr -13Cr -169.71Cr -13Cr -13Cr -569.06Cr
Net Debt 13Cr 0 12Cr 11Cr 9.86Cr 19Cr 1.27TCr 19Cr 126.61Cr 50Cr 630.9Cr 50Cr 49Cr 2.12TCr 14Cr 0 12Cr 11Cr 10Cr 19Cr 1.3TCr 19Cr 130.03Cr 51Cr 647.94Cr 51Cr 50Cr 2.17TCr
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
31/26/31 ILA 315.00 +9.34% 86,173
30/26/30 ILA 288.10 +4.12% 67,984
29/26/29 ILA 276.70 -2.81% 31,443
28/26/28 ILA 284.70 -2.23% 37,932
27/26/27 ILA 291.20 -0.99% 1,19,264
  1. Stock Market
  2. Stocks
  3. INCR Stock